PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32699853-3	2020	In vitro, binding of ACE2 and heparin to spike protein ectodomains occurs independently and a ternary complex can be generated using heparin as a template.	Heparin	30-37	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	41-46	
32699853-3	2020	In vitro, binding of ACE2 and heparin to spike protein ectodomains occurs independently and a ternary complex can be generated using heparin as a template.	Heparin	133-140	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	41-46	
32699853-5	2020	Unfractionated heparin, non-anticoagulant heparin, treatment with heparin lyases, and purified lung heparan sulfate potently block spike protein binding and infection by spike protein-pseudotyped virus and SARS-CoV-2 virus.	Heparin	15-22	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	131-136	
32699853-5	2020	Unfractionated heparin, non-anticoagulant heparin, treatment with heparin lyases, and purified lung heparan sulfate potently block spike protein binding and infection by spike protein-pseudotyped virus and SARS-CoV-2 virus.	Heparin	15-22	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	170-175	
32699853-5	2020	Unfractionated heparin, non-anticoagulant heparin, treatment with heparin lyases, and purified lung heparan sulfate potently block spike protein binding and infection by spike protein-pseudotyped virus and SARS-CoV-2 virus.	Heparin	42-49	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	131-136	
32699853-5	2020	Unfractionated heparin, non-anticoagulant heparin, treatment with heparin lyases, and purified lung heparan sulfate potently block spike protein binding and infection by spike protein-pseudotyped virus and SARS-CoV-2 virus.	Heparin	42-49	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	170-175	
32699853-5	2020	Unfractionated heparin, non-anticoagulant heparin, treatment with heparin lyases, and purified lung heparan sulfate potently block spike protein binding and infection by spike protein-pseudotyped virus and SARS-CoV-2 virus.	Heparin	42-49	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	131-136	
32699853-5	2020	Unfractionated heparin, non-anticoagulant heparin, treatment with heparin lyases, and purified lung heparan sulfate potently block spike protein binding and infection by spike protein-pseudotyped virus and SARS-CoV-2 virus.	Heparin	42-49	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	170-175